Search - tctmd.com

Displaying 481 - 500 of 879

Sort: Relevancy | Date

Presentation TCT 2015

Rationale for EBC Main: LM 1 vs 2 Stents and IVUS vs No IVUS

Presenter: David E. Kandzari, David Hildick-Smith

October 15, 2015

Presentation TCT 2015

Are All Metallic Stents Equal for LM Bifurcations?

Presenter: David E. Kandzari, Nicolas Foin

October 15, 2015

Presentation TCT 2015

EBC 2 Study: One vs 2 Stents for Large Side Branches

Presenter: Thierry Lefevre, Leif Thuesen, David Hildick-Smith

October 14, 2015

Presentation TCT 2015

Nordic IV Study: One vs 2 Stents

Presenter: Thierry Lefevre, Leif Thuesen, Jens Flensted Lassen

October 14, 2015

Presentation TCT 2015

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Presenter: William A. Gray, D. Christopher Metzger, Piotr Musialek

October 14, 2015

Presentation TCT 2015

One vs 2 Stents: Is the Debate Over?

Presenter: Antonio L. Bartorelli, Yves R. Louvard, Terje K. Steigen

October 14, 2015

Presentation TCT 2015

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent Versus Bare Metal Stents in Patients With Coronary Artery Disease at High Risk for Bleeding

Presenter: Cindy L. Grines, Philip M. Urban

October 14, 2015

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Cindy L. Grines, Upendra Kaul

October 14, 2015

Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Cindy L. Grines, Bo Xu

October 14, 2015

Presentation TCT 2015

MASTER: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction

Presenter: Bernard J. Gersh, Thomas F. Luscher, Cesar Moris

October 14, 2015

Presentation TCT 2015

Mexico Presents: In-Stent Restenosis Treated With Atherectomy and Implantation of 3 Stents

Presenter: Marco A. Alcocer-Gamba, Stefan Mot, Ivo Petrov, Ramiro Trillo, JOSE R Azpiri-Lopez

October 14, 2015

Presentation TCT 2015

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Presenter: Andrea Abizaid, Daniel Burkhoff, Tzung-Dau Wang

October 14, 2015

Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of 2 Sirolimus-Eluting Bioresorbable-Polymer–Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Bo Xu

October 14, 2015

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Upendra Kaul

October 14, 2015

News Conference News TCT 2015

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Conference News TCT 2015

TCT Remembers Liliana Grinfeld, MD, PhD

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

Advertisement

Rationale for EBC Main: LM 1 vs 2 Stents and IVUS vs No IVUS

Are All Metallic Stents Equal for LM Bifurcations?

EBC 2 Study: One vs 2 Stents for Large Side Branches

Nordic IV Study: One vs 2 Stents

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

One vs 2 Stents: Is the Debate Over?

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent Versus Bare Metal Stents in Patients With Coronary Artery Disease at High Risk for Bleeding

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

MASTER: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction

Mexico Presents: In-Stent Restenosis Treated With Atherectomy and Implantation of 3 Stents

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

PANDA III: A Prospective Randomized Trial of 2 Sirolimus-Eluting Bioresorbable-Polymer–Based Metallic Stents With Varying Elution and Absorption Kinetics

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

TCT Remembers Liliana Grinfeld, MD, PhD

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content